Our work on a prognostic imaging marker for breast cancer was published in Radiology.
The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.
CA 15-3 is a widely used tumor marker for breast cancer.
GATA3 is a transcription factor and has been proven to be a useful marker for breast carcinoma.
Overall, miR-564 is a potential dual inhibitor of PI3K and MAPK pathways, and may be an attractive target and prognostic marker for breast cancer.
Jessica Queller ("Cancer and the Maiden," Op-Ed, March 5) poignantly describes the dilemma she faces now that she knows that she has a genetic marker for breast cancer (BRCA1).
Importantly, lower levels of miR-564 expression or higher levels of target genes expression is associated with poor prognosis and survival suggesting miR-564 or its targets in combination as a potential marker for breast cancer progression.
Previous data suggested that GNA13 was significantly upregulated in more aggressive breast cancer cells, and elevated GNA13 expression might be used as a potential marker for breast cancer progression16.
Therefore, our findings provide a potential diagnostic and prognostic marker for breast cancer metastasis.
Cancer antigen 15-3 (considered considered as a marker for breast cancer recurrence.
Recently, a lipidomics study on breast cancer patients identified increased plasma ether-linked phosphatidylcholine species as a diagnostic marker for breast cancer (Chen et al., 2016).
